Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Journal of Extracellular Vesicles|March 26, 2025
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 TherapyLinzi Sun, Xiaoting Wei, Qian Zhao, et al.European Journal of Cancer (Oxford, England : 1990)|March 26, 2021
Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathwayLili Mao, Jie Dai, Yabin Cao, et al.Frontiers in Oncology|July 18, 2022
Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal MelanomaLirui Tang, Xiaoting Wei, Caili Li, et al.Theranostics|March 15, 2019
MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK PathwaysMeng Ma, Jie Dai, Huan Tang, et al.Journal of the National Cancer Center|July 22, 2024
Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancerHuizi Lei, Yun Ling, Pei Yuan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplificationJun Guo, Lu Si, Yan Kong, et al.Theranostics|May 13, 2022
Erratum: MicroRNA-23a-3p Inhibits Mucosal Melanoma Growth and Progression through Targeting Adenylate Cyclase 1 and Attenuating cAMP and MAPK Pathways: ErratumMeng Ma, Jie Dai, Huan Tang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2019
Axitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB TrialXinan Sheng, Xieqiao Yan, Zhihong Chi, et al.The British Journal of Dermatology|January 18, 2022
Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective studyXiaoting Wei, Di Wu, Yu Chen, et al.Journal of Hematology & Oncology|January 16, 2019
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patientsBixia Tang, Xieqiao Yan, Xinan Sheng, et al.Pageof 13